Sign Up to like & get
recommendations!
1
Published in 2018 at "Cell"
DOI: 10.1016/j.cell.2018.11.049
Abstract: Monoclonal antibodies against calcitonin gene-related peptide (CGRP) or its receptor (CLR + RAMP1) offer considerable improvements over existing drugs in migraine prophylaxis and are the first designed to act on the trigeminal pain system. Erenumab…
read more here.
Keywords:
cgrp;
antibodies prophylaxis;
cgrp antibodies;
prophylaxis migraine ... See more keywords